Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

  1. Fernandez-Fernandez, B.
  2. Fernandez-Prado, R.
  3. Górriz, J.L.
  4. Martinez-Castelao, A.
  5. Navarro-González, J.F.
  6. Porrini, E.
  7. Soler, M.J.
  8. Ortiz, A.
Journal:
Clinical Kidney Journal

ISSN: 2048-8513 2048-8505

Year of publication: 2019

Volume: 12

Issue: 3

Pages: 313-321

Type: Article

DOI: 10.1093/CKJ/SFZ070 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals